Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 3
1966 2
1967 3
1968 4
1969 1
1971 3
1974 1
1975 3
1977 4
1978 2
1979 3
1980 4
1981 2
1982 1
1984 1
1985 4
1986 1
1987 5
1988 5
1989 14
1990 6
1991 9
1992 13
1993 8
1994 9
1995 3
1996 3
1997 8
1998 4
1999 4
2000 5
2001 3
2003 1
2004 2
2006 1
2007 1
2008 2
2009 3
2010 1
2011 6
2012 4
2013 4
2014 11
2015 1
2016 5
2017 5
2018 3
2020 3
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

189 results
Results by year
Filters applied: . Clear all
Page 1
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial.
Zuraw B, Lumry WR, Johnston DT, Aygören-Pürsün E, Banerji A, Bernstein JA, Christiansen SC, Jacobs JS, Sitz KV, Gower RG, Gagnon R, Wedner HJ, Kinaciyan T, Hakl R, Hanzlíková J, Anderson JT, McNeil DL, Fritz SB, Yang WH, Tachdjian R, Busse PJ, Craig TJ, Li HH, Farkas H, Best JM, Clemons D, Cornpropst M, Dobo SM, Iocca HA, Kargl D, Nagy E, Murray SC, Collis P, Sheridan WP, Maurer M, Riedl MA. Zuraw B, et al. Among authors: sheridan wp. J Allergy Clin Immunol. 2021 Jul;148(1):164-172.e9. doi: 10.1016/j.jaci.2020.10.015. Epub 2020 Oct 21. J Allergy Clin Immunol. 2021. PMID: 33098856 Free article.
Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema.
Aygören-Pürsün E, Bygum A, Grivcheva-Panovska V, Magerl M, Graff J, Steiner UC, Fain O, Huissoon A, Kinaciyan T, Farkas H, Lleonart R, Longhurst HJ, Rae W, Triggiani M, Aberer W, Cancian M, Zanichelli A, Smith WB, Baeza ML, Du-Thanh A, Gompels M, Gonzalez-Quevedo T, Greve J, Guilarte M, Katelaris C, Dobo S, Cornpropst M, Clemons D, Fang L, Collis P, Sheridan W, Maurer M, Cicardi M. Aygören-Pürsün E, et al. Among authors: sheridan w. N Engl J Med. 2018 Jul 26;379(4):352-362. doi: 10.1056/NEJMoa1716995. N Engl J Med. 2018. PMID: 30044938 Free article. Clinical Trial.
Oral berotralstat for the prophylaxis of hereditary angioedema attacks in patients in Japan: A phase 3 randomized trial.
Ohsawa I, Honda D, Suzuki Y, Fukuda T, Kohga K, Morita E, Moriwaki S, Ishikawa O, Sasaki Y, Tago M, Chittick G, Cornpropst M, Murray SC, Dobo SM, Nagy E, Van Dyke S, Reese L, Best JM, Iocca H, Collis P, Sheridan WP, Hide M. Ohsawa I, et al. Among authors: sheridan wp. Allergy. 2021 Jun;76(6):1789-1799. doi: 10.1111/all.14670. Epub 2020 Dec 23. Allergy. 2021. PMID: 33247955 Free PMC article. Clinical Trial.
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.
Warren TK, Wells J, Panchal RG, Stuthman KS, Garza NL, Van Tongeren SA, Dong L, Retterer CJ, Eaton BP, Pegoraro G, Honnold S, Bantia S, Kotian P, Chen X, Taubenheim BR, Welch LS, Minning DM, Babu YS, Sheridan WP, Bavari S. Warren TK, et al. Among authors: sheridan wp. Nature. 2014 Apr 17;508(7496):402-5. doi: 10.1038/nature13027. Epub 2014 Mar 2. Nature. 2014. PMID: 24590073 Free PMC article.
A direct-acting antiviral drug abrogates viremia in Zika virus-infected rhesus macaques.
Lim SY, Osuna CE, Best K, Taylor R, Chen E, Yoon G, Kublin JL, Schalk D, Schultz-Darken N, Capuano S, Safronetz D, Luo M, MacLennan S, Mathis A, Babu YS, Sheridan WP, Perelson AS, Whitney JB. Lim SY, et al. Among authors: sheridan wp. Sci Transl Med. 2020 Jun 10;12(547):eaau9135. doi: 10.1126/scitranslmed.aau9135. Sci Transl Med. 2020. PMID: 32522808 Free PMC article.
Pharmacology of the colony-stimulating factors.
Morstyn G, Lieschke GJ, Sheridan W, Layton J, Cebon J. Morstyn G, et al. Among authors: sheridan w. Trends Pharmacol Sci. 1989 Apr;10(4):154-9. doi: 10.1016/0165-6147(89)90168-5. Trends Pharmacol Sci. 1989. PMID: 2665248 Review.
Early clinical trials with colony-stimulating factors.
Morstyn G, Lieschke GJ, Cebon J, Dührsen U, Villeval JL, Sheridan W, McGrath K, Layton JE. Morstyn G, et al. Among authors: sheridan w. Cancer Invest. 1989;7(5):443-56. doi: 10.3109/07357908909041375. Cancer Invest. 1989. PMID: 2482790 Review. No abstract available.
BCX4430 - A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease.
Taylor R, Kotian P, Warren T, Panchal R, Bavari S, Julander J, Dobo S, Rose A, El-Kattan Y, Taubenheim B, Babu Y, Sheridan WP. Taylor R, et al. Among authors: sheridan wp. J Infect Public Health. 2016 May-Jun;9(3):220-6. doi: 10.1016/j.jiph.2016.04.002. Epub 2016 Apr 16. J Infect Public Health. 2016. PMID: 27095300 Free PMC article. Review.
189 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page